Your browser doesn't support javascript.
loading
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
Wei, Brian M; Fox, Lindy P; Kaffenberger, Benjamin H; Korman, Abraham M; Micheletti, Robert G; Mostaghimi, Arash; Noe, Megan H; Rosenbach, Misha; Shinkai, Kanade; Kwah, Jason H; Phillips, Elizabeth J; Bolognia, Jean L; Damsky, William; Nelson, Caroline A.
Affiliation
  • Wei BM; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
  • Fox LP; Department of Dermatology, University of California, San Francisco, California.
  • Kaffenberger BH; Department of Dermatology, The Ohio State University, Columbus, Ohio.
  • Korman AM; Department of Dermatology, The Ohio State University, Columbus, Ohio.
  • Micheletti RG; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Mostaghimi A; Department of Dermatology, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Noe MH; Department of Dermatology, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Rosenbach M; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Shinkai K; Department of Dermatology, University of California, San Francisco, California.
  • Kwah JH; Department of Medicine, Section of Rheumatology, Allergy and Immunology, Yale School of Medicine, New Haven, Connecticut.
  • Phillips EJ; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Bolognia JL; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
  • Damsky W; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Nelson CA; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Electronic address: Caroline.Nelson@yale.edu.
J Am Acad Dermatol ; 90(5): 885-908, 2024 May.
Article in En | MEDLINE | ID: mdl-37516359
Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction (SCAR) characterized by an exanthem, fever, and hematologic and visceral organ involvement. Anticonvulsants, antibiotics, and allopurinol are the most common triggers. The pathogenesis involves a complex interplay between drugs, viruses, and the immune system primarily mediated by T-cells. DiHS/DRESS typically presents with a morbilliform eruption 2-6 weeks after drug exposure, and is associated with significant morbidity, mortality, and risk of relapse. Long-term sequelae primarily relate to organ dysfunction and autoimmune diseases. Part I of this continuing medical education activity on DiHS/DRESS provides an update on epidemiology, novel insights into pathogenesis, and a description of clinicopathological features and prognosis.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Eosinophilia / Drug Hypersensitivity Syndrome Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Eosinophilia / Drug Hypersensitivity Syndrome Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2024 Type: Article